TY - JOUR AU - van de Vijver, M. J. AU - He, Y. D. AU - van't Veer, L. J. AU - Dai, H. AU - Hart, A. A. AU - Voskuil, D. W. AU - Schreiber, G. J. AU - Peterse, J. L. AU - Roberts, C. AU - Marton, M. J. PY - 2002 DA - 2002// TI - A gene-expression signature as a predictor of survival in breast cancer JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMoa021967 DO - 10.1056/NEJMoa021967 ID - van de Vijver2002 ER - TY - JOUR AU - van 't Veer, L. J. AU - Dai, H. AU - van de Vijver, M. J. AU - He, Y. D. AU - Hart, A. A. AU - Mao, M. AU - Peterse, H. L. AU - van der Kooy, K. AU - Marton, M. J. AU - Witteveen, A. T. PY - 2002 DA - 2002// TI - Gene expression profiling predicts clinical outcome of breast cancer JO - Nature VL - 415 UR - https://doi.org/10.1038/415530a DO - 10.1038/415530a ID - van 't Veer2002 ER - TY - JOUR AU - Paik, S. AU - Shak, S. AU - Tang, G. AU - Kim, C. AU - Baker, J. AU - Cronin, M. AU - Baehner, F. L. AU - Walker, M. G. AU - Watson, D. AU - Park, T. PY - 2004 DA - 2004// TI - A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa041588 DO - 10.1056/NEJMoa041588 ID - Paik2004 ER - TY - JOUR AU - Paik, S. AU - Tang, G. AU - Shak, S. AU - Kim, C. AU - Baker, J. AU - Kim, W. AU - Cronin, M. AU - Baehner, F. L. AU - Watson, D. AU - Bryant, J. PY - 2006 DA - 2006// TI - Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.7985 DO - 10.1200/JCO.2005.04.7985 ID - Paik2006 ER - TY - JOUR AU - Gyorffy, B. AU - Hatzis, C. AU - Sanft, T. AU - Hofstatter, E. AU - Aktas, B. AU - Pusztai, L. PY - 2015 DA - 2015// TI - Multigene prognostic tests in breast cancer: past, present, future JO - Breast Cancer Res VL - 17 UR - https://doi.org/10.1186/s13058-015-0514-2 DO - 10.1186/s13058-015-0514-2 ID - Gyorffy2015 ER - TY - JOUR AU - Harris, L. AU - Fritsche, H. AU - Mennel, R. AU - Norton, L. AU - Ravdin, P. AU - Taube, S. AU - Somerfield, M. R. AU - Hayes, D. F. AU - Bast, R. C. PY - 2007 DA - 2007// TI - American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2007.14.2364 DO - 10.1200/JCO.2007.14.2364 ID - Harris2007 ER - TY - JOUR AU - Albain, K. S. AU - Barlow, W. E. AU - Shak, S. AU - Hortobagyi, G. N. AU - Livingston, R. B. AU - Yeh, I. T. AU - Ravdin, P. AU - Bugarini, R. AU - Baehner, F. L. AU - Davidson, N. E. PY - 2010 DA - 2010// TI - Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(09)70314-6 DO - 10.1016/S1470-2045(09)70314-6 ID - Albain2010 ER - TY - JOUR AU - Lo, S. S. AU - Mumby, P. B. AU - Norton, J. AU - Rychlik, K. AU - Smerage, J. AU - Kash, J. AU - Chew, H. K. AU - Gaynor, E. R. AU - Hayes, D. F. AU - Epstein, A. PY - 2010 DA - 2010// TI - Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2008.20.2119 DO - 10.1200/JCO.2008.20.2119 ID - Lo2010 ER - TY - JOUR AU - Ademuyiwa, F. O. AU - Miller, A. AU - O'Connor, T. AU - Edge, S. B. AU - Thorat, M. A. AU - Sledge, G. W. AU - Levine, E. AU - Badve, S. PY - 2011 DA - 2011// TI - The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort JO - Breast Cancer Res Treat VL - 126 UR - https://doi.org/10.1007/s10549-010-1329-6 DO - 10.1007/s10549-010-1329-6 ID - Ademuyiwa2011 ER - TY - JOUR AU - Geffen, D. B. AU - Abu-Ghanem, S. AU - Sion-Vardy, N. AU - Braunstein, R. AU - Tokar, M. AU - Ariad, S. AU - Delgado, B. AU - Bayme, M. AU - Koretz, M. PY - 2011 DA - 2011// TI - The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdq769 DO - 10.1093/annonc/mdq769 ID - Geffen2011 ER - TY - JOUR AU - Partin, J. F. AU - Mamounas, E. P. PY - 2011 DA - 2011// TI - Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer JO - Ann Surg Oncol VL - 18 UR - https://doi.org/10.1245/s10434-011-1698-z DO - 10.1245/s10434-011-1698-z ID - Partin2011 ER - TY - JOUR AU - Albanell, J. AU - Gonzalez, A. AU - Ruiz-Borrego, M. AU - Alba, E. AU - Garcia-Saenz, J. A. AU - Corominas, J. M. AU - Burgues, O. AU - Furio, V. AU - Rojo, A. AU - Palacios, J. PY - 2012 DA - 2012// TI - Prospective transGEICAM study of the impact of the 21-gene recurrence score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mdr278 DO - 10.1093/annonc/mdr278 ID - Albanell2012 ER - TY - JOUR AU - Joh, J. E. AU - Esposito, N. N. AU - Kiluk, J. V. AU - Laronga, C. AU - Lee, M. C. AU - Loftus, L. AU - Soliman, H. AU - Boughey, J. C. AU - Reynolds, C. AU - Lawton, T. J. PY - 2011 DA - 2011// TI - The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists JO - Oncologist VL - 16 UR - https://doi.org/10.1634/theoncologist.2011-0045 DO - 10.1634/theoncologist.2011-0045 ID - Joh2011 ER - TY - JOUR AU - Eiermann, W. AU - Rezai, M. AU - Kummel, S. AU - Kuhn, T. AU - Warm, M. AU - Friedrichs, K. AU - Schneeweiss, A. AU - Markmann, S. AU - Eggemann, H. AU - Hilfrich, J. PY - 2013 DA - 2013// TI - The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use JO - Ann oncol VL - 24 UR - https://doi.org/10.1093/annonc/mds512 DO - 10.1093/annonc/mds512 ID - Eiermann2013 ER - TY - JOUR AU - Carlson, J. J. AU - Roth, J. A. PY - 2013 DA - 2013// TI - The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis JO - Breast Cancer Res Treat VL - 141 UR - https://doi.org/10.1007/s10549-013-2666-z DO - 10.1007/s10549-013-2666-z ID - Carlson2013 ER - TY - JOUR AU - Dinan, M. A. AU - Mi, X. AU - Reed, S. D. AU - Lyman, G. H. AU - Curtis, L. H. PY - 2015 DA - 2015// TI - Association between use of the 21-gene recurrence score assay and receipt of chemotherapy among Medicare beneficiaries with early-stage breast cancer, 2005-2009 JO - JAMA oncology VL - 1 UR - https://doi.org/10.1001/jamaoncol.2015.2722 DO - 10.1001/jamaoncol.2015.2722 ID - Dinan2015 ER - TY - STD TI - Levine MN, Julian JA, Bedard PL, Eisen A, Trudeau ME, Higgins B, Bordeleau L, Pritchard KI. Prospective evaluation of the 21-gene recurrence score assay for breast cancer decision-making in Ontario. J Clin Oncol. J Clin Oncol. 2016;34:1065–71. ID - ref17 ER - TY - JOUR AU - Mamounas, E. P. AU - Tang, G. AU - Fisher, B. AU - Paik, S. AU - Shak, S. AU - Costantino, J. P. AU - Watson, D. AU - Geyer, C. E. AU - Wickerham, D. L. AU - Wolmark, N. PY - 2010 DA - 2010// TI - Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20 JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.23.7610 DO - 10.1200/JCO.2009.23.7610 ID - Mamounas2010 ER - TY - JOUR AU - Jegadeesh, N. K. AU - Kim, S. AU - Prabhu, R. S. AU - Oprea, G. M. AU - Yu, D. S. AU - Godette, K. G. AU - Zelnak, A. B. AU - Mister, D. AU - Switchenko, J. M. AU - Torres, M. A. PY - 2015 DA - 2015// TI - The 21-gene recurrence score and locoregional recurrence in breast cancer patients JO - Ann Surg Oncol VL - 22 UR - https://doi.org/10.1245/s10434-014-4252-y DO - 10.1245/s10434-014-4252-y ID - Jegadeesh2015 ER - TY - JOUR AU - Solin, L. J. AU - Gray, R. AU - Goldstein, L. J. AU - Recht, A. AU - Baehner, F. L. AU - Shak, S. AU - Badve, S. AU - Perez, E. A. AU - Shulman, L. N. AU - Martino, S. PY - 2012 DA - 2012// TI - Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the eastern cooperative oncology group E2197 study JO - Breast Cancer Res Treat VL - 134 UR - https://doi.org/10.1007/s10549-012-2072-y DO - 10.1007/s10549-012-2072-y ID - Solin2012 ER - TY - STD TI - Turashvili G, Chou JF, Brogi E, Morrow M, Dickler M, Norton L, Hudis C, Wen HY. 21-gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2017;166(1):69–76. ID - ref21 ER - TY - STD TI - Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer Staging Manual, 7th edn. New York, NY: Springer; 2010. ID - ref22 ER - TY - JOUR AU - Hudis, C. A. AU - Barlow, W. E. AU - Costantino, J. P. AU - Gray, R. J. AU - Pritchard, K. I. AU - Chapman, J. A. AU - Sparano, J. A. AU - Hunsberger, S. AU - Enos, R. A. AU - Gelber, R. D. PY - 2007 DA - 2007// TI - Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.10.3523 DO - 10.1200/JCO.2006.10.3523 ID - Hudis2007 ER - TY - JOUR AU - Hassett, M. J. AU - Silver, S. M. AU - Hughes, M. E. AU - Blayney, D. W. AU - Edge, S. B. AU - Herman, J. G. AU - Hudis, C. A. AU - Marcom, P. K. AU - Pettinga, J. E. AU - Share, D. PY - 2012 DA - 2012// TI - Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.38.5740 DO - 10.1200/JCO.2011.38.5740 ID - Hassett2012 ER - TY - STD TI - Wen HY, Krystel-Whittemore M, Patil S, Pareja F, Bowser ZL, Dickler MN, Norton L, Morrow M, Hudis CA, Brogi E. Breast carcinoma with an Oncotype Dx recurrence score <18: rate of distant metastases in a large series with clinical follow-up. Cancer. 2017;123(1):131–7. ID - ref25 ER - TY - JOUR AU - Yamashita, H. AU - Ogiya, A. AU - Shien, T. AU - Horimoto, Y. AU - Masuda, N. AU - Inao, T. AU - Osako, T. AU - Takahashi, M. AU - Endo, Y. AU - Hosoda, M. PY - 2016 DA - 2016// TI - Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer JO - Breast Cancer VL - 23 UR - https://doi.org/10.1007/s12282-015-0649-0 DO - 10.1007/s12282-015-0649-0 ID - Yamashita2016 ER - TY - JOUR AU - Sestak, I. AU - Cuzick, J. PY - 2015 DA - 2015// TI - Markers for the identification of late breast cancer recurrence JO - Breast Cancer Res VL - 17 UR - https://doi.org/10.1186/s13058-015-0516-0 DO - 10.1186/s13058-015-0516-0 ID - Sestak2015 ER - TY - JOUR AU - Wapnir, I. L. AU - Anderson, S. J. AU - Mamounas, E. P. AU - Geyer, C. E. AU - Jeong, J. H. AU - Tan-Chiu, E. AU - Fisher, B. AU - Wolmark, N. PY - 2006 DA - 2006// TI - Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and bowel project node-positive adjuvant breast cancer trials JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.3273 DO - 10.1200/JCO.2005.04.3273 ID - Wapnir2006 ER - TY - JOUR AU - Fredholm, H. AU - Magnusson, K. AU - Lindstrom, L. S. AU - Garmo, H. AU - Falt, S. E. AU - Lindman, H. AU - Bergh, J. AU - Holmberg, L. AU - Ponten, F. AU - Frisell, J. PY - 2016 DA - 2016// TI - Long-term outcome in young women with breast cancer: a population-based study JO - Breast Cancer Res Treat VL - 160 UR - https://doi.org/10.1007/s10549-016-3983-9 DO - 10.1007/s10549-016-3983-9 ID - Fredholm2016 ER - TY - JOUR AU - Partridge, A. H. AU - Hughes, M. E. AU - Warner, E. T. AU - Ottesen, R. A. AU - Wong, Y. N. AU - Edge, S. B. AU - Theriault, R. L. AU - Blayney, D. W. AU - Niland, J. C. AU - Winer, E. P. PY - 2016 DA - 2016// TI - Subtype-dependent relationship between young age at diagnosis and breast cancer survival JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.65.8013 DO - 10.1200/JCO.2015.65.8013 ID - Partridge2016 ER - TY - JOUR AU - Sparano, J. A. PY - 2006 DA - 2006// TI - TAILORx: trial assigning individualized options for treatment (Rx) JO - Clin Breast Cancer VL - 7 UR - https://doi.org/10.3816/CBC.2006.n.051 DO - 10.3816/CBC.2006.n.051 ID - Sparano2006 ER - TY - STD TI - Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Perez EA, Olson JA Jr, et al. Prospective validation of a 21-gene expression assay in breast cancer. N Engl J Med. 2015;373(21):2005–14. ID - ref32 ER - TY - JOUR AU - Ramsey, S. D. AU - Barlow, W. E. AU - Gonzalez-Angulo, A. M. AU - Tunis, S. AU - Baker, L. AU - Crowley, J. AU - Deverka, P. AU - Veenstra, D. AU - Hortobagyi, G. N. PY - 2013 DA - 2013// TI - Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes JO - Contemp Clin Trials VL - 34 UR - https://doi.org/10.1016/j.cct.2012.09.003 DO - 10.1016/j.cct.2012.09.003 ID - Ramsey2013 ER -